Skip to content
10-Q

Quarterly Report

MediXall Group, Inc.

0001079973-24-000912

← back to feed
Filed
Jun 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Jun 18, 2024 159.76M sh
Current Liabilities Q3 2023 · Sep 30, 2023 $5.7M
Current Liabilities Q3 2023 · Dec 31, 2022 $4.34M
Total Liabilities Q3 2023 · Sep 30, 2023 $5.7M
Total Liabilities Q3 2023 · Dec 31, 2022 $4.53M
Current Assets Q3 2023 · Sep 30, 2023 $13.15K
Current Assets Q3 2023 · Dec 31, 2022 $11.5K
Total Assets Q3 2023 · Sep 30, 2023 $455.5K
Total Assets Q3 2023 · Dec 31, 2022 $862.01K
Shares Diluted Q3 2023 · Sep 30, 2022 116.89M sh
Shares Diluted Q3 2023 · Sep 30, 2022 115.9M sh
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$2.96M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$2.92M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$1.76M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$675.5K
Stockholders Equity Q3 2023 · Dec 31, 2021 −$340.12K
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.01
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.05
Eps Basic Q3 2023 · Sep 30, 2022 −$0.01
Eps Basic Q3 2023 · Sep 30, 2022 −$0.05
Net Income Q3 2023 · Sep 30, 2022 −$1.08M
Net Income Q3 2023 · Sep 30, 2022 −$5.05M
Net Income Q3 2023 · Jun 30, 2022 −$1.55M
Net Income Q3 2023 · Mar 31, 2022 −$2.41M
Gross Profit Q3 2023 · Sep 30, 2022 $20.77K
Gross Profit Q3 2023 · Sep 30, 2022 $39.03K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $0
Cost Of Revenue Q3 2023 · Sep 30, 2022 $0
Revenue Q3 2023 · Sep 30, 2022 $20.77K
Revenue Q3 2023 · Sep 30, 2022 $39.03K